Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib for chronic graft-versus-host disease
NCT02513498Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Dec 2015
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in chronic graft-versus-host disease (cGVHD), sponsored by Fred Hutchinson Cancer Center. Started Dec 2015; status: completed.
02
Drugs
ixazomib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT02513498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513498.